Original Article

4-Methyl-N-(Piperidin-1-Ylmethylene) Benzenesulfonamide (PMSA) Promotes Ferroptosis of Tumor Cells by Targeting the KEAP1-NRF2-GPX4 Axis

Abstract

Background: We aimed to investigate the effect of 4-methyl-N-(piperidin-1-ylmethylene) benzenesulfonamide (PMSA) on tumor cell proliferation, migration, ferroptosis, and the potential molecular mechanism of ferroptosis in tumor cells.
Methods: PMSA was produced in the marine biomedical research institute of Guangdong Medical University (Zhanjiang, China) and used for tumor cells treatment. MTT and cell colony formation assays were used to measure the inhibition of tumor cell proliferation, the scratch assay was used to identified the suppression of tumor cell migration, the death of tumor cells was measured by Annexin-V-FITC/PI staining, the level of ferroptosis-relative lipid ROS in tumor cells was measured by flow cytometry and MDA detection kit, and the expression of ferroptosis-relative protein was measured by Western blot. The Discovery Studio system was used for molecular docking and the binding ability was measured by cellular thermal shift assay.
Results: The PMSA we produced inhibited tumor cell proliferation, colony formation, migration and triggered cell death, and Fer-1 could reverse these effects. The amount of ROS and MDA levels in tumor cells was also markedly raised by PMSA. PMSA treatment significantly reduced the expression of SLC7A11/XCT, NRF2, and GPX4 in tumor cells. The phosphorylation level of NRF2 was also decreased. Through molecular docking, it was discovered that PMSA could bind to NRF2 and thereby block its activity.
Conclusion: The KEAP1-NRF2-GPX4 axis was the target of PMSA’s anti-tumor action, which results in ferroptosis of tumor cells. This demonstrated that the compound has the potential to be used as a candidate for anti-tumor drugs.

1. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW (2013). Cancer genome landscapes. Science, 339 (6127): 1546-1558.
2. Liu D, Li G, Jia A, Zhao Y, Cao C, Xing X (2018). Regulatory mechanism of ferroptosis, a new mode of cell death. Trop J Pharm Res, 17: 2309-2316.
3. Viswanathan VS, Ryan MJ, Dhruv HD, et al (2017). Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature, 547(7664): 453-457.
4. Mou Y, Wang J, Wu J, et al (2019). Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol, 12(1): 34.
5. Chen X, Kang R, Kroemer G, Tang D (2021). Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol, 18: 280-296.
6. Cheng M, Wang P, Wu D (2022). Diosmetin alleviates periodontitis by inhibiting oxidative stress and pyroptosis via Nrf2/NF-κB/NLRP3 axis. Trop J Pharm Res, 21: 2303-2308.
7. Rojo de la Vega M, Chapman E, Zhang DD (2018). NRF2 and the Hallmarks of Cancer. Cancer Cell, 34(1): 21-43.
8. Wang W, Yang X, Chen Q, et al (2020). Sinomenine attenuates septic-associated lung injury through the Nrf2-Keap1 and autophagy. J Pharm Pharmacol, 72(2): 259-270.
9. Doll S, Proneth B, Tyurina YY, et al (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol, 13(1): 91-98.
10. Shen K, Wang X, Wang Y, et al (2023). miR-125b-5p in adipose derived stem cells exosome alleviates pulmonary microvascular endothelial cells ferroptosis via Keap1/Nrf2/GPX4 in sepsis lung injury. Redox Biol, 62: 102655.
11. Dodson M, Castro-Portuguez R, Zhang DD (2019). NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol, 23: 101107.
12. Liang C, Zhang X, Yang M, Dong X (2019). Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater, 31(51): e1904197.
13. Bistrović A, Krstulović L, Harej A, et al (2018). Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer. Eur J Med Chem, 143: 1616-1634.
14. Zhao Y, Zhou Z, Chen M, Yang W (2021). Copper-Catalyzed One-Pot Synthesis of N-Sulfonyl Amidines from Sulfonyl Hydrazine, Terminal Alkynes and Sulfonyl Azides. Molecules, 26(12): 3700.
15. Ghorab MM, Ragab FA, Heiba HI, Soliman AM (2016). Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents. Eur J Med Chem, 117: 8-18.
16. Zhang S, Xiong P, Ma Y, et al (2022). Transformation of food waste to source of antimicrobial proteins by black soldier fly larvae for defense against marine Vibrio parahaemolyticus. Sci Total Environ, 826: 154163.
17. Nguyen LXT, Troadec E, Kalvala A, et al (2019). The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML. J Cell Physiol, 234(8): 14040-14049.
18. Soliman AM, Karam HM, Mekkawy MH, et al (2020). Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinazolin-4(3H)-ones carrying a sulfonamide moiety. Eur J Med Chem, 200: 112467.
19. Duong HQ, Yi YW, Kang HJ, et al (2014). Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine. Int J Oncol, 44(3): 959-969.
20. Kirtonia A, Sethi G, Garg M (2020). The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci, 77(22): 4459-4483.
Files
IssueVol 53 No 10 (2024) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v53i10.16705
Keywords
Ferroptosis Benzenesulfonamide NF-E2-related factor-2 Glutathione peroxidase 4

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Sun B, Zhao G, Zhang L, Wu B, Hou J. 4-Methyl-N-(Piperidin-1-Ylmethylene) Benzenesulfonamide (PMSA) Promotes Ferroptosis of Tumor Cells by Targeting the KEAP1-NRF2-GPX4 Axis. Iran J Public Health. 2024;53(10):2279-2289.